1. Home
  2. IEP vs IRTC Comparison

IEP vs IRTC Comparison

Compare IEP & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Icahn Enterprises L.P.

IEP

Icahn Enterprises L.P.

HOLD

Current Price

$7.63

Market Cap

4.7B

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$112.49

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IEP
IRTC
Founded
1987
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.8B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
IEP
IRTC
Price
$7.63
$112.49
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$207.54
AVG Volume (30 Days)
929.3K
639.6K
Earning Date
05-28-2026
05-25-2026
Dividend Yield
26.35%
N/A
EPS Growth
N/A
61.71
EPS
N/A
N/A
Revenue
$9,658,000,000.00
$747,138,000.00
Revenue This Year
N/A
$19.58
Revenue Next Year
N/A
$15.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.24
52 Week Low
$7.08
$92.52
52 Week High
$9.99
$210.01

Technical Indicators

Market Signals
Indicator
IEP
IRTC
Relative Strength Index (RSI) 40.14 24.93
Support Level $7.08 N/A
Resistance Level $8.33 $161.36
Average True Range (ATR) 0.20 5.80
MACD -0.06 -1.26
Stochastic Oscillator 15.56 2.48

Price Performance

Historical Comparison
IEP
IRTC

About IEP Icahn Enterprises L.P.

Icahn Enterprises LP provides diversified business services in the United States. The company operates its business through varied segments which include Investment, Automotive, Energy, Food Packaging, Real Estate, Pharma, and Home Fashion. Among these, the Energy segment derives the maximum revenue from the company. Geographically, it generates maximum revenue from the United States.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: